VALORACLE

Market Access Intelligence. Always On. Radically Faster.

AI-native, expert-directed Operations-as-a-Service for pharmaceutical pricing, HEOR, and market access.

Request a Demo See How It Works View Sample Deliverable

ED-001Phase III OS data (KEYNOTE-xxx)MAPPED

ED-002PRO / HRQoL endpoint (EQ-5D-5L)MAPPED

NEED-014CMS cost-effectiveness thresholdIDENTIFIED

GAP-007Missing real-world subgroup analysisFLAGGED

GAP-012No head-to-head comparator dataFLAGGED

ACT-003Commission retrospective claims studyPROPOSED

ACT-005Develop ICER-ready BIM modelPROPOSED

ED-009Indirect treatment comparison (NMA)MAPPED

GAP-019Insufficient long-term safety follow-upFLAGGED

ACT-008Engage with NICE early scientific advicePROPOSED

The Platform

The Market Access Platform That Replaces the Consulting Engagement

ValOracle is an AI-native, expert-directed Operations-as-a-Service platform that delivers the same depth and rigor as a traditional consulting engagement — strategic assessments, evidence gap analyses, payer landscape reviews — at a fraction of the cost and turnaround time. Every output is cross-referenced, traceable, and built on structured domain intelligence across eight interconnected market access disciplines.

Operations-as-a-Service

Not a Tool. Not a Dashboard. A Full Consulting Replacement.

ValOracle covers every core domain of pharmaceutical market access strategy under a single platform. No SOWs. No staffing delays. No inconsistency between analysts. One integrated system that produces institutional-quality deliverables on demand.

Pricing & Contracting Strategy
Market Access Strategy
Reimbursement & Coverage Policy
HEOR & Evidence Strategy
Payer Intelligence & Landscape
Stakeholder Engagement
Commercial Operations
Global Cross-Functional Strategy

NEED-014CMS cost-effectiveness threshold

↓ cross-reference

GAP-007Missing real-world subgroup analysis

↓ generates

ACT-003Commission retrospective claims study

↓ validates

REV-001Synthetic expert panel review

↓ outputs

DEL-001Strategic Assessment Document

Domain Coverage

Eight Domains. One Platform. Zero SOWs.

Pricing & Contracting Strategy

Launch pricing, contracting frameworks, and gross-to-net optimization.

Launch price recommendations by market
Contracting scenario modeling
Gross-to-net waterfall analysis
Rebate and discount structure design
International reference pricing impact

Market Access Strategy

Payer-facing value narratives, access barriers, and formulary positioning.

Access barrier identification and mitigation
Formulary positioning strategy
Value proposition development
Market access dossier framework
Managed care pull-through planning

Reimbursement & Coverage Policy

Coverage pathway mapping, coding analysis, and policy monitoring.

Coverage pathway analysis (Medicare, commercial)
Coding and billing strategy (J-code, NDC)
LCD/NCD policy monitoring
Site-of-care reimbursement analysis
Prior authorization landscape review

HEOR & Evidence Strategy

Evidence gap analysis, value framework alignment, and outcomes strategy.

Evidence gap analysis with trace IDs
ICER / NICE / AMNOG value framework alignment
HEOR study recommendations
Budget impact and cost-effectiveness modeling guidance
Publication and congress strategy

Payer Intelligence & Landscape

Payer segmentation, formulary tracking, and competitive payer positioning.

Payer segmentation and tiering
Formulary and utilization management tracking
Competitive payer positioning analysis
Regional payer landscape reviews
PBM and IDN coverage mapping

Stakeholder Engagement

Advisory board planning, KOL mapping, and payer engagement strategy.

Advisory board design and question guides
KOL and payer influence mapping
Medical and commercial liaison alignment
Congress engagement strategy
Patient advocacy landscape review

Commercial Operations

Distribution, channel strategy, and trade and distribution planning.

Distribution channel strategy
Specialty pharmacy network design
Hub services and patient support programs
Trade and distribution planning
Buy-and-bill vs. specialty pathway analysis

Global Cross-Functional Strategy

Multi-market launch sequencing, HTA alignment, and cross-functional coordination.

Multi-market launch sequencing
HTA submission alignment across geographies
Cross-functional workstream coordination
Global value dossier framework
Reference pricing and external dependency mapping

Process

From Asset Profile to Strategic Assessment in Days

Define Your Asset

Upload your asset profile — indication, clinical program, target markets, and strategic questions.

Landscape Scan

The Diagnostic Engine maps the competitive, regulatory, and payer landscape across your selected markets.

Strategic Assessment

The Strategist Engine generates cross-referenced evidence gap analyses, pricing frameworks, and access strategies.

Synthetic Expert Review

AI-simulated expert panels review and challenge the strategic output for rigor and completeness.

Deliverable

A consulting-grade strategic assessment document — structured, traceable, and ready for internal review.

Deliverable

Consulting-Grade Output. Every Time.

Every ValOracle assessment follows a standardized 9-section structure designed to match the depth and rigor of a traditional consulting deliverable.

#	Section	Description
01	Executive Summary	Key findings, strategic recommendations, and priority actions
02	Situation Analysis	Disease landscape, competitive environment, and unmet need
03	Payer Needs & Evaluation Criteria	Decision drivers, formulary requirements, and value thresholds
04	Evidence Gap Analysis	Mapped evidence with trace IDs (ED/NEED/GAP/ACT)
05	Access Evaluation Factors	Coverage pathway, prior auth, step therapy, and utilization management
06	Roadmap of Proposed Activities	Prioritized action items with owners and timelines
07	Country Synthesis	Market-by-market findings and cross-market comparison
08	Strategic Guidance	Senior-level strategic recommendations and risk considerations
09	Reference Appendices	Source documents, methodology notes, and full evidence index

Pricing

Transparent Pricing. No SOWs. No Surprises.

Per-Assessment Pricing

Landscape Scan1,000 tokens / market

Strategic Assessment2,000 tokens / market

Full Assessment3,000 tokens / market

7-Market Full Assessment$21,000

Subscription Tiers

Base24,000 tokens · $22,000

Professional60,000 tokens · $50,000

Enterprise135,000 tokens · $100,000

Start with Base. Scale to Enterprise.

Comparison

What Takes Them Months Takes Us Days.

Dimension	Traditional Consulting	ValOracle OaaS
Engagement Model	SOW-based, project-by-project	Token-based, on-demand
Cost	$150K–$500K per engagement	$1K–$3K per market assessment
Consistency	Analyst-dependent, variable	Standardized 9-section structure
Scalability	Headcount-constrained	Run 50 markets in parallel
Cross-Referencing	Manual, incomplete	Automated trace IDs across all evidence
Quality Assurance	Peer review (availability-dependent)	Synthetic expert panel review
Data Security	Shared drives, email attachments	Zero data leakage architecture
Speed to Insight	6–16 weeks	Days
Audit Trail	Slide decks, meeting notes	Full evidence lineage with trace IDs

Leadership

Built by a Market Access Strategist. For Market Access Strategists.

Nathan White

Founder & CEO

Nathan has spent over a decade in pharmaceutical pricing, HEOR, and market access consulting — leading engagements for mid-market biotech and global pharma across dozens of therapeutic areas and markets. ValOracle was born from a simple observation: the consulting model is too slow, too expensive, and too inconsistent for the pace of modern drug development. The platform encodes the strategic rigor of a senior consulting team into a system that runs on demand.